ANEXT (Shanghai) Biotechnology Co., Ltd. is a technology company devoted to the creation of ground-breaking cellular therapies. Using its mass-produced and universally applicable products ANEXT Super Delivery and ANEXT Smart Ex, the company has built a cellular synthetic biology manufacturing platform that spans the entire chain of technologies from research and development to production. By drastically improving production efficiency, cutting down on production time, and decreasing costs associated with product development and production, the implementation of these technologies will revolutionize the manufacture of biologically active chemicals.
Exosomes were recently found and "naturally domesticated" by ANEXT, which changed the way they are typically delivered pharmaceuticals and made it possible to create novel medications. ANEXT has committed to the research and development of a cellular exosome therapeutic pipeline for the treatment of cancer.
Together with the Oriental Beauty Valley, ANEXT built the "Regenerative Medicine Research Institute" and collaborated with the State Key Laboratory of Bioreactor at East China University of Science and Technology, which allowed for the large-scale synthesis of exosomes.
With an eye toward the future, ANEXT intends to pursue its purpose of "Saving Lives - Restoring Lives" by developing gradually and sustainably, realizing disruptive potential, and creating the world's first exosome factory.
Saving Lives with
New Medicine
Practice.
Address: No. 1788, West Huifeng Road, Fengxian District, Shanghai, China
phone: 02160133720
